Drug regulation

You have access
Canada’s approach to biosimilars questioned
Paul Christopher Webster

CMAJ November 03, 2015 187 (16) 1199; DOI: https://doi.org/10.1503/cmaj.109-5169
You have access
Medicine and society: LSD: a new treatment emerging from the past
Erika Dyck

CMAJ October 06, 2015 187 (14) 1079-1080; DOI: https://doi.org/10.1503/cmaj.141358
You have access
Generic drugs in Canada: an examination of tiered pricing
Aidan Hollis

CMAJ October 06, 2015 187 (14) 1033-1034; DOI: https://doi.org/10.1503/cmaj.150395
You have access
More regulation not the answer for opioids
Lauren Vogel

CMAJ September 22, 2015 187 (13) 957; DOI: https://doi.org/10.1503/cmaj.109-5135
You have access
Regulating electronic cigarettes: finding the balance between precaution and harm reduction
Ronald Labonté and Raphael Lencucha

CMAJ September 08, 2015 187 (12) 862-864; DOI: https://doi.org/10.1503/cmaj.150347
You have access
Medicine and society: The rhetoric of female sexual dysfunction: faux feminism and the FDA
Judy Z. Segal

CMAJ September 08, 2015 187 (12) 915-916; DOI: https://doi.org/10.1503/cmaj.150363
You have access
Dispensaries: the Wild West of Vancouver
Shannon Lough

CMAJ August 11, 2015 187 (11) E345-E346; DOI: https://doi.org/10.1503/cmaj.109-5116
You have access
Can reporting of adverse drug reactions create safer systems while improving health data?
Corinne Hohl, Joel R. Lexchin and Ellen Balka

CMAJ August 11, 2015 187 (11) 789-790; DOI: https://doi.org/10.1503/cmaj.150057
You have access
Is Canada’s drug safety network effective?
Carolyn Brown

CMAJ May 19, 2015 187 (8) 553-554; DOI: https://doi.org/10.1503/cmaj.109-5028
You have access
Canada can afford universal pharmacare — no more excuses
Matthew B. Stanbrook

CMAJ April 21, 2015 187 (7) 475; DOI: https://doi.org/10.1503/cmaj.150281

Main menu

User menu

Search

Drug regulation

Pages

Content

Information for

About